Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1R,4S)-4-amino-2-cyclopentene-1-carboxylic acid + 2-oxoglutarate
? + L-glutamate
-
analogue of 4-aminobutanoate, vigabatrin
-
?
(4R)-4-amino-1-cyclopentene-1-carboxylic acid + 2-oxoglutarate
4-oxo-1-cyclopentene1-carboxylic acid + L-glutamate
-
analogue of 4-aminobutanoate, vigabatrin
-
?
(R)-4-amino-3-fluorobutanoic acid
4-aminobut-2-enoic acid + HF
-
-
?
(R,S)-4-amino-3-fluorobutanoic acid
4-aminobut-2-enoic acid + HF
neither enantiomer is a substrate for transamination. The rate of elimination of HF from the (R)-enantiomer is at least 10 times greater than that for the (S)-enantiomer
-
?
(S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid + 2-oxoglutarate
4-oxo-4,5-dihydro-2-thiophenecarboxylic acid + L-glutamate
-
mechanism-based inactivator that partly undergoes inactivation
-
?
1H-tetrazole-5-butanamine + 2-oxoglutarate
(1H-tetrazol-5-yl)-butyraldehyde + L-glutamate
-
-
-
?
1H-tetrazole-5-ethanamine + 2-oxoglutarate
(1H-tetrazol-5-yl)-acetaldehyd + L-glutamate
-
-
-
?
1H-tetrazole-5-propanamine + 2-oxoglutarate
(1H-tetrazol-5-yl)-propionaldehyde + L-glutamate
-
-
-
?
3-(aminomethyl)benzoic acid + 2-oxoglutarate
3-(iminomethyl)benzoic acid + L-glutamate
3.4% of the activity with 4-aminobutanoate
-
?
3-aminoisobutanoate + 2-oxoglutarate
L-glutamate + 3-oxoisobutanoate
3-aminopropanesulfonate + 2-oxoglutarate
3-sulfopropanal + L-glutamate
substrate is homotaurine
-
?
4-(aminomethyl)-1H-pyrrole-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
4-(aminomethyl)furan-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
4-(aminomethyl)furan-3-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
4-(aminomethyl)thiophene-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
4-(aminomethyl)thiophene-3-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
4-aminobutanoate + pyruvate
4-oxobutanoate + alanine
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
4-aminobutyrate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
5-(aminomethyl)-1H-pyrrole-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
5-(aminomethyl)furan-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
5-(aminomethyl)thiophene-2-carboxylic acid + 2-oxoglutarate
?
-
-
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
5-aminovaleric acid + pyruvate
5-oxopentanoate + L-alanine
6-aminohexanoate + 2-oxoglutarate
L-glutamate + 6-oxohexanoate
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
cadaverine + 2-oxoglutarate
L-glutamate + 5-aminopentanal
-
-
-
?
cadaverine + 2-oxoglutarate
L-glutamate + ?
-
poor amino donor
-
r
D-lysine + 2-oxoglutarate
L-glutamate + 5-aminopentanol
DL-3-amino-1-cyclopentene-1-carboxylic acid + 2-oxoglutarate
3-oxo-1-cyclopentene-1-carboxylic acid + L-glutamate
-
analogue of 4-aminobutanoate, vigabatrin
-
?
DL-3-hydroxy-4-aminobutanoate + 2-oxoglutarate
L-glutamate + 3-hydroxy-4-oxobutanoate
DL-ornithine + 2-oxoglutarate
L-glutamate + 4-methyl-2-oxopentanoate
gamma-aminobutyric acid
?
-
-
?
hypotaurine + 2-oxoglutarate
L-glutamate + 2-oxoethanesulfinic acid
-
poor amino donor
-
r
L-3-aminoisobutanoate + 2-oxoglutarate
?
-
-
-
?
L-lysine + 2-oxoglutarate
L-glutamate + (S)-2-amino-6-oxohexanoate
-
-
i.e. L-2-aminoadipate-6-semialdehyde
?
L-ornithine + 2-oxoglutarate
L-glutamate + (S)-2-amino-5-oxopentanoate
-
-
i.e. L-glutamate-gamma-semialdehyde
?
putrescine + 2-oxoglutarate
L-glutamate + 4-aminobutanal
-
-
-
?
putrescine + 2-oxoglutarate
L-glutamate + 4-aminobutanol
-
poor amino donor
-
r
tetrazole-5-butanamine + 2-oxoglutarate
?
-
-
-
?
tetrazole-5-ethanamine + 2-oxoglutarate
?
-
-
-
?
tetrazole-5-propanamine + 2-oxoglutarate
?
-
-
-
?
[2-(aminomethyl)phenyl]acetic acid + 2-oxoglutarate
(2-formylphenyl)acetic acid + L-glutamate
5.65% of the activity with 4-aminobutanoate
-
?
[3-(aminomethyl)phenyl]acetic acid + 2-oxoglutarate
(3-formylphenyl)acetic acid + L-glutamate
0.78% of the activity with 4-aminobutanoate
-
?
additional information
?
-
3-aminoisobutanoate + 2-oxoglutarate

L-glutamate + 3-oxoisobutanoate
-
-
-
r
3-aminoisobutanoate + 2-oxoglutarate
L-glutamate + 3-oxoisobutanoate
-
transamination at 55% the rate of 4-aminobutanoate
-
r
3-aminoisobutanoate + 2-oxoglutarate
L-glutamate + 3-oxoisobutanoate
-
-
-
r
3-aminoisobutanoate + 2-oxoglutarate
L-glutamate + 3-oxoisobutanoate
-
transamination at 14% the rate of 4-aminobutanoate
-
r
4-aminobutanoate + 2-oxoglutarate

4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
Candida guilliermondii var. membranaefaciens
-
best substrate
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
Candida guilliermondii var. membranaefaciens Y43
-
best substrate
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
specific for 2-oxoglutarate
i.e. succinic semialdehyde + L-Glu
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
involved in gamma-aminobutyrate metabolism
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
no substrate: 2-oxoglutarate
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
no substrate: 2-oxoglutarate
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
best substrate at pH 9.5 as well as at pH 8.5
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
inducible enzyme
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
involved in 4-aminobutanoate metabolism via the GABA shunt pathway
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
involved in 4-aminobutanoate metabolism via the GABA shunt pathway
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
best substrate
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
-
r
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
key-reaction of gamma-aminobutyrate(GABA)-shunt or bypass
-
?
4-aminobutanoate + 2-oxoglutarate
4-oxobutanoate + L-glutamate
-
involved in beta-alanine metabolism
-
?
4-aminobutanoate + glyoxylate

4-oxobutanoate + glycine
-
-
?
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
-
-
?
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
-
-
?
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
-
?
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
at 16% of the activity of 2-oxoglutarate
-
r
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
at 16% of the activity of 2-oxoglutarate
-
r
4-aminobutanoate + glyoxylate
4-oxobutanoate + glycine
-
-
?
4-aminobutanoate + pyruvate

4-oxobutanoate + alanine
-
not using 2-oxoglutarate
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + alanine
-
not using 2-oxoglutarate
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + alanine
-
at 7% of the activity of 2-oxoglutarate
-
r
4-aminobutanoate + pyruvate
4-oxobutanoate + alanine
-
at 7% of the activity of 2-oxoglutarate
-
r
4-aminobutanoate + pyruvate

4-oxobutanoate + L-alanine
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
-
?
4-aminobutanoate + pyruvate
4-oxobutanoate + L-alanine
-
-
?
5-aminopentanoate + 2-oxoglutarate

L-glutamate + 5-oxopentanoate
Candida guilliermondii var. membranaefaciens
-
transamination at 45% the rate of 4-aminobutanoate
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
Candida guilliermondii var. membranaefaciens Y43
-
transamination at 45% the rate of 4-aminobutanoate
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
-
-
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
-
transamination at 48% the rate of 4-aminobutanoate
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
-
transamination at 60% the rate of 4-aminobutanoate
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
-
-
-
?
5-aminopentanoate + 2-oxoglutarate
L-glutamate + 5-oxopentanoate
-
transamination at 85% the rate of 4-aminobutanoate
-
?
5-aminovaleric acid + pyruvate

5-oxopentanoate + L-alanine
-
-
47.7% of the activity with 4-aminobutanoate
?
5-aminovaleric acid + pyruvate
5-oxopentanoate + L-alanine
-
-
47.7% of the activity with 4-aminobutanoate
?
6-aminohexanoate + 2-oxoglutarate

L-glutamate + 6-oxohexanoate
Candida guilliermondii var. membranaefaciens
-
transamination at 27% the rate of 4-aminobutanoate
-
?
6-aminohexanoate + 2-oxoglutarate
L-glutamate + 6-oxohexanoate
Candida guilliermondii var. membranaefaciens Y43
-
transamination at 27% the rate of 4-aminobutanoate
-
?
6-aminohexanoate + 2-oxoglutarate
L-glutamate + 6-oxohexanoate
-
-
-
?
6-aminohexanoate + 2-oxoglutarate
L-glutamate + 6-oxohexanoate
-
transamination at 29% the rate of 4-aminobutanoate
-
?
6-aminohexanoate + 2-oxoglutarate
L-glutamate + 6-oxohexanoate
-
-
-
?
beta-alanine + 2-oxoglutarate

malonic semialdehyde + L-glutamate
Candida guilliermondii var. membranaefaciens
-
poor substrate
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
Candida guilliermondii var. membranaefaciens Y43
-
poor substrate
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
?
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
?
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
effective amino group donor
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
?
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
?
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
?
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
-
-
r
beta-alanine + 2-oxoglutarate
malonic semialdehyde + L-glutamate
-
effective amino group donor
-
r
D-lysine + 2-oxoglutarate

L-glutamate + 5-aminopentanol
-
poor amino donor
-
r
D-lysine + 2-oxoglutarate
L-glutamate + 5-aminopentanol
-
poor amino donor
-
r
DL-3-hydroxy-4-aminobutanoate + 2-oxoglutarate

L-glutamate + 3-hydroxy-4-oxobutanoate
-
-
-
r
DL-3-hydroxy-4-aminobutanoate + 2-oxoglutarate
L-glutamate + 3-hydroxy-4-oxobutanoate
-
-
-
r
DL-3-hydroxy-4-aminobutanoate + 2-oxoglutarate
L-glutamate + 3-hydroxy-4-oxobutanoate
-
transamination at 20% the rate of 4-aminobutanoate
-
r
DL-ornithine + 2-oxoglutarate

L-glutamate + 4-methyl-2-oxopentanoate
-
poor amino donor
-
?
DL-ornithine + 2-oxoglutarate
L-glutamate + 4-methyl-2-oxopentanoate
-
poor amino donor
-
?
additional information

?
-
cannot utilize 2-oxoglutarate as amino acceptor
-
?
additional information
?
-
-
cannot utilize 2-oxoglutarate as amino acceptor
-
?
additional information
?
-
-
cannot utilize 2-oxoglutarate as amino acceptor
-
?
additional information
?
-
-
cannot utilize 2-oxoglutarate as amino acceptor
-
?
additional information
?
-
Candida guilliermondii var. membranaefaciens
-
no substrates are L-aminovalerate, L-norleucine, straight alpha-amino acids, diamino acids
-
?
additional information
?
-
Candida guilliermondii var. membranaefaciens Y43
-
no substrates are L-aminovalerate, L-norleucine, straight alpha-amino acids, diamino acids
-
?
additional information
?
-
-
does not use pyruvate as amino acceptor
-
?
additional information
?
-
does not use pyruvate as amino acceptor
-
?
additional information
?
-
does not use pyruvate as amino acceptor
-
?
additional information
?
-
-
overview
-
?
additional information
?
-
-
no amino acceptors are oxaloacetate, pyruvate
-
?
additional information
?
-
-
no amino acceptors are 2-oxobutyrate, phenylpyruvate, alpha-ketoadipate
-
?
additional information
?
-
-
no amino acceptors are oxaloacetate, pyruvate
-
?
additional information
?
-
-
enzyme is induced in cells grown on 4-guanidinobutyrate, 4-aminobutyrate, or putrescine as the only carbon and nitrogen source. GABAT functions in the biosynthesis of arginine by converting N2-acetyl-L-glutamate 5-semialdehyde to N2-acetyl-L-ornithine as well as in catabolic reactions during growth on putrescine or 4-guanidinobutyrate but not during growth on arginine
-
?
additional information
?
-
-
overview
-
?
additional information
?
-
-
no amino acceptors are oxaloacetate, pyruvate
-
?
additional information
?
-
-
no substrate: lysine
-
?
additional information
?
-
-
no amino acceptors are ketomalonic acid, alpha-ketoisovaleric acid
-
?
additional information
?
-
-
aspartate, L-2,4-diaminoglutarate, alanine, D-glutamate or malonic semialdehyde cannot replace L-glutamate or succinic semialdehyde in the reverse reaction
-
?
additional information
?
-
-
GABase activity against beta-alanine, epsilon-amino-n-caproic acid, L-ornithine, L-lysine, and L-aspartic acid is between 0.3 to 2.3% of the activity against 4-aminobutanoate
-
?
additional information
?
-
-
GABase activity against beta-alanine, epsilon-amino-n-caproic acid, L-ornithine, L-lysine, and L-aspartic acid is between 0.3 to 2.3% of the activity against 4-aminobutanoate
-
?
additional information
?
-
-
no substrates are taurine, 3-aminopropane sulfonate, glycine
-
?
additional information
?
-
-
no substrates are taurine, 3-aminopropane sulfonate, glycine
-
?
additional information
?
-
-
overview
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+/-)-(1S,2R,4S,5S)-4-amino-6,6-difluorobicyclo[3.1.0]hexane-2-carboxylic acid
-
10 mM, weak, reversible inhibitor
(+/-)-(1S,2S,4S,5S)-4-amino-6,6-difluorobicyclo[3.1.0]hexane-2-carboxylic acid
-
10 mM, weak, reversible inhibitor
(+/-)piperidine-3-sulfonic acid
-
-
(1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid
-
mechanism-based inactivation, adduct formed is derived from enamine mechanism
(1R,4S)-4-amino-2-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
(1R,4S)-4-amino-3-fluorocyclopent-2-enecarboxylic acid
-
weak reversible inhibition in the presence of beta-mercaptoethanol
(1R,4S)-4-amino-3-pentafluoroethylcyclopent-2-enecarboxylic acid
-
weak reversible inhibition in the presence of beta-mercaptoethanol
(1R,4S)-4-amino-3-trifluoromethylcyclopent-2-enecarboxylic acid
-
irreversible inhibition in the presence of beta-mercaptoethanol
(1S,2S,3E)-2-amino-3-(fluoromethylidene)cyclopentanecarboxylic acid
monofluorinated analog of inhibitor CPP-115. Compound produces a metabolite that induces disruption of the Glu270-Arg445 salt bridge of GABA transaminase to accommodate interaction between the metabolite formyl group and Arg445. The inactivation mechanism is initiated by Schiff base formation with the active site pyridoxal 5'-phosphate, followed by gamma-proton removal
(1S,2S,3Z)-2-amino-3-(fluoromethylidene)cyclopentanecarboxylic acid
monofluorinated analog of inhibitor CPP-115. Compound produces a metabolite that induces disruption of the Glu270-Arg445 salt bridge of GABA transaminase to accommodate interaction between the metabolite formyl group and Arg445. The inactivation mechanism is initiated by Schiff base formation with the active site pyridoxal 5'-phosphate, followed by gamma-proton removal
(1S,3S)-(Z)-3-amino-4-(2,2,2-trifluoroethylidene)cyclopentanecarboxylic acid
-
inhibition in the presence of beta-mercaptoethanol
(1S,3S)-3-amino-4-(2,2,2-trifluoro-1-trifluoromethylethylidene)-cyclopentanecarboxylic acid
-
weak reversible inhibition in the presence of beta-mercaptoethanol
(1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid
-
potent irreversible inhibitor
(1S,4R)-4-amino-2-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
(1S,4S)-2-(difluoromethylidene)-4-(1H-tetrazol-5-yl)cyclopentanamine
-
time-dependent inactivation, ratio kinact/KI value at pH 8.0 is 2.48 per min and mM
(2E)-4-methylpentan-2-one N-(2,4-dimethylphenyl)semicarbazone
-
57% inhibition at 0.125 mM
(2E)-butan-2-one N-(2,4-dimethylphenyl)semicarbazone
-
89% inhibition at 0.0625 mM
(4R)-4-amino-1-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
(4S)-4-amino-1-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
(R,S)-4-amino-3-fluorobutanoic acid
the (R)-enantiomer inhibits the transamination of gamma-aminobutanoic acid 10 times more effectively than the (S)-enantiomer. On binding of free 4-amino-3-fluorobutanoic acid to enzyme the optimal conformation places the C-NH3 + and C-F bonds gauche in the (R)-enantiomer but anti in the (S)-enantiomer
(S)-4-amino-4,5-dihydro-2-thiophenecarboxylic acid
-
mechanism-based inactivator, reacts via aromatization mechanism
(Z)-4-amino-2-butenoic acid
-
-
1-(4-acetylphenyl)-3-(4-bromophenyloxy)-pyrrolidine-2,5-dione
-
1-(4-acetylphenyl)-3-(salicyldehydoxy)-pyrrolidine-2,5-dione
-
1H-tetrazole-5-(alpha-vinyl-propanamine)
-
-
2,4-dimethylphenyl semicarbazide hydrochloride
-
90% inhibition at 0.0625 mM
2-Aminobenzenesulfonate
-
-
2-aminobutanoate
Candida guilliermondii var. membranaefaciens
-
-
2-aminoethane phosphonic acid
-
-
2-N-(acetylamino)cyclohexane sulfonic acid
-
-
3-(aminomethyl)benzoic acid
poor competitive inhibitor
3-aminocyclohexanecarboxylic acid
-
10 mM
3-chloro-1-(4-hydroxyphenyl)propan-1-one
-
irreversible and potent inhibitor, about 30% residual activity at 0.06 mM, 2-oxoglutarate prevents the enzyme from inactivation
3-Chloro-4-aminobutanoate
-
-
3-Mercaptopropionic acid
-
-
3-Methyl-2-benzothiazolone hydrazone hydrochloride
-
-
3-Phenyl-4-aminobutanoate
-
-
4-(aminomethyl)-1H-pyrrole-2-carboxylic acid
-
-
4-(aminomethyl)furan-2-carboxylic acid
-
-
4-(aminomethyl)furan-3-carboxylic acid
-
-
4-(aminomethyl)thiophene-2-carboxylic acid
-
-
4-(aminomethyl)thiophene-3-carboxylic acid
-
-
4-acryloylphenol
-
potent inhibitor
4-amino-2-fluorobutanoate
-
reversible, competitive to 4-aminobutanoate
4-amino-5-fluoropentanoic acid
-
potent irreversible inhibitor
4-Amino-hex-5-enoic acid
-
substrate analogue, irreversible, in vitro and in vivo
4-Aminohex-5-ynoic acid
-
irreversible, in vitro and in vivo, kinetics
4-ethynyl-4-aminobutanoate
-
4-hydroxybenzylamine
-
IC50: 0.0154 mM, competitive inhibition
5,5'-dithiobis-2-nitrobenzoic acid
-
95% loss of activity
5-(aminomethyl)-1H-pyrrole-2-carboxylic acid
-
-
5-(aminomethyl)furan-2-carboxylic acid
-
-
5-(aminomethyl)thiophene-2-carboxylic acid
-
-
5-amino-1,3-cyclohexadienylcarboxylate
-
5-Iodouracil
-
84% inhibition at 1 mM
6-Azauracil
-
63% inhibition at 1 mM, reversible by dialysis, not by pyridoxal phosphate addition
alpha-alanine
Candida guilliermondii var. membranaefaciens
-
-
Ba2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
Baclofen
-
injection of 0.01 mg/g body weight reduces GABA-T mRNA level 2fold; i.p. injection of sexually regressed female goldfish results in significant increase in serum luteinising hormone after 6 h. About 2fold decrease both in glutamic acid decarboxylase 67 and gamma-aminobutanoate transaminase mRNa in the hypothalamus
beta-cypermethrin
GABA transaminase activity detected is significantly decreased in the cerebral cortex of mice 2 h after beta-cypermethrin administration. beta-Cypermethrin (80 mg/kg) significantly increases GABA levels in the cerebral cortex of mice, at both 2 and 4 h after treatment, compared with the control. The number of positive granules is increased in the cerebral cortex of mice 4 h after exposure to 80 mg/kg beta-cypermethrin. No significant changes are found in glutamate decarboxylase activity, or the expression of GABA transaminase protein and GABAB receptors mRNA, in the cerebral cortex of mice, except that 80 mg/kg beta-cypermethrin causes a significant decrease in GABAA receptors mRNA expression 4 h after administration
Branched-chain fatty acids
-
Ca2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
Cd2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
cis-3-aminocyclohex-4-ene-1-carboxylic acid
-
conformationally rigid analogue of vigabatrin, mechanism
Co2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
cycloserine
-
90% inhibition at 1 mM
Divalent metal ions
-
with decreasing efficiency: Hg2+, Cd2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
-
DL-3-amino-1-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
DL-trans-4-amino-2-cyclopentene-1-carboxylic acid
-
analogue of 4-aminobutanoate, vigabatrin
ethanolamine O-sulfate
-
active-site directed, ir, in vitro and in vivo, kinetics
ethylamine-2-sulfonic acid
-
i.e. taurine, competitive
falcarindiol
-
active-site directed, irreversible, 23% residual activity at 14 mM, isolate of root of Angelica dahurica
gamma-vinyl 4-aminobutanoate
-
0.1 mM, complete inhibition
gastrodigenin
-
30.87% inhibition at 0.01 mM
glycine
competitive inhibitor of pyruvate-dependent GABA-T activity
imperatorin
-
active-site directed, irreversible, 14% residual activity at 14 mM, isolate of root of Angelica dahurica
Lysyl reagents
-
2-oxoglutarate protects
-
Mg2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
Mn2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
N-(4-bromophenyl)-3-(4-chlorophenyl)-6,7-dimethoxy-3a,4-dihydroindeno[1,2-c]pyrazole-2(3H)-carboxamide
molecular docking to propose the binding interaction with a three-dimensional structural model of the gamma-aminobutyric acid amino transferase. The compound successfully binds to the active pocket of the enzyme with good predicted affinities
N-(4-bromophenyl)-3-(4-fluorophenyl)-6,7-dimethoxy-3a,4-dihydroindeno[1,2-c]pyrazole-2(3H)-carboxamide
molecular docking to propose the binding interaction with a three-dimensional structural model of the gamma-aminobutyric acid amino transferase. The compound successfully binds to the active pocket of the enzyme with good predicted affinities
Ni2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
oleanolic acid
-
20.2% inhibition at 0.1 mg/ml
propan-2-one N-(2,4-dimethylphenyl)semicarbazone
-
44% inhibition at 0.25 mM
rosmarinic acid
-
40.2% inhibition at 0.1 mg/ml
S-vigabatrin
-
ratio kinact/KI is1.7 per min and mM at pH 8.5, 0.11per min and mM at pH 6.5, respectively
Sr2+
-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
tetrazole-5-(alpha-vinyl-propanamine)
-
-
trimethylcitryl-beta-D-galactopyranoside
-
56.8% inhibition at 0.01 mM
ursolic acid
-
19.9% inhibition at 0.1 mg/ml
Valproic acid
-
65.4% inhibition at 0.01 mM
[2-(aminomethyl)phenyl]acetic acid
poor competitive inhibitor
[3-(aminomethyl)phenyl]acetic acid
poor competitive inhibitor
2,4-diaminobutanoate

-
not
2,4-diaminobutanoate
-
kinetics
2,4-diaminobutanoate
-
not
2-oxoglutarate

Candida guilliermondii var. membranaefaciens
-
-
2-oxoglutarate
substrate inhibition
4-aminohex-5-enoic acid

-
i.e. gamma-vinyl GABA, competitive, does not affect transamination process of 2-oxoglutarate
4-aminohex-5-enoic acid
-
-
4-hydroxybenzaldehyde

-
IC50: 0.0165 mM, competitive inhibition
4-hydroxybenzaldehyde
-
competitive inhibitor of GABA transaminase
4-hydroxybenzaldehyde
-
potent inhibitor
5-fluorouracil

-
weak
Aminooxyacetate

-
Aminooxyacetate
-
80% inhibition at 2 mM
Aminooxyacetate
-
99% inhibition at 1 mM
Aminooxyacetate
-
kinetics
beta-Alanine

competitive inhibitor of pyruvate-dependent GABA-T activity
beta-Alanine
Candida guilliermondii var. membranaefaciens
-
-
beta-Alanine
moderate inhibitor; moderate inhibitor
Branched-chain fatty acids

-
-
-
Branched-chain fatty acids
-
-
-
Butyric acid

Candida guilliermondii var. membranaefaciens
-
-
carbonyl reagents

-
-
-
Cu2+

-
order of decreasing inhibitory potency: Hg2+, Cd2+, Cu2+, Co2+, Ba2+, Sr2+, Ni2+, Mn2+, Ca2+, Mg2+
D-cycloserine

-
-
D-penicillamine

-
-
ethanol

-
10% v/v, weak
ethanol
-
in presence of disulfiram, i.e. N,N,Nā,Nā-tetraethylthiuram disulfide
gabaculine

-
i.e. 5-amino-1,3-cyclohexadienylcarboxylate, ir, kinetics; not its tert-butylcarbamate derivative
gabaculine
-
80% inhibition at 2 mM
gabaculine
-
98% inhibition at 1 mM
gabaculine
-
IC50: 0.0018 mM, potent and irreversible inhibitor
gabaculine
-
highly specific GABAtransaminase inhibitor
HgCl2

-
strong, 50% inhibition at 0.007 mM
HgCl2
-
24% inhibition at 0.05 mM, pyridoxal 5'-phosphate protects
hydrazine

-
-
hydroxylamine

-
-
monoiodoacetate

-
not
Muscimol

-
injection of 0.001 mg/g body weight reduces GABA-T mRNA level 15fold; i.p. injection of sexually regressed female goldfish results in significant increase in serum luteinising hormone after 6 h. About 10fold decrease in glutamic acid decarboxylase 65 and 15fold in gamma-aminobutanoate transaminase mRNa in the hypothalamus
Muscimol
-
i.e. 5-(aminomethyl)-3-isoxazolol
Muscimol
-
i.e. 5-(aminomethyl)-3-isoxazolol
ornithine

competitive inhibitor of pyruvate-dependent GABA-T activity
ornithine
moderate inhibitor; moderate inhibitor
p-chloromercuribenzoate

-
strong
p-chloromercuribenzoate
-
-
p-chloromercuribenzoate
-
-
p-chloromercuribenzoate
-
-
phenylhydrazine

-
-
propionic acid

Candida guilliermondii var. membranaefaciens
-
-
SH-group reagents

-
-
-
SH-group reagents
-
2-mercaptoethanol or DTT reactivates
-
SH-group reagents
-
2-oxoglutarate protects
-
Succinic semialdehyde

-
-
Succinic semialdehyde
-
substrate inhibition
vigabatrin

competitive inhibitor of pyruvate-dependent GABA-T activity
vigabatrin
-
complete inhibition at 0.5 mM
vigabatrin
-
triggers a massive synaptic plasticity in retinal areas showing a normal layering of the retina shown by the withdrawal of rod but not cone photoreceptor terminals from the outer plexiform layers towards their cell bodies. Both rod bipolar cells and horizontal cells exhibit dendritic sprouting into the photoreceptor nuclear layer. Withdrawing rod photoreceptors appear to form ectopic contacts with growing postsynaptic dendrites. Neuronal plasticity is highly suggestive of an impaired glutamate release by photoreceptors
vigabatrin
-
gamma-vinyl GABA, anticonvulsant, induces spontaneous release of 4-aminobutanoate
vigabatrin
-
IC50: 0.35 mM
vigabatrin
-
chronical administration via drinking water at 30 and 81 mg per kg and day. Vigabatrin completely and reversibly eliminates the psychophysical evidence of tinnitus at both doses
additional information

no substrate inhibition: 4-aminobutanoate
-
additional information
-
no substrate inhibition: 4-aminobutanoate
-
additional information
-
no inhibition by 6-azauridine, 6-azauridine 5'-phosphate, uracil, (iso)orotic acid, cytosine, thymine, dihydrothymine, 2-thiocytosine, thiourea; not inhibitory: 5-aminouracil
-
additional information
-
-
-
additional information
-
no inhibition by chelating agents, non-substrate L- or D-amino acids, metal ions
-
additional information
-
the methanol extract from Melissa officinalis is a potent in vitro inhibitor of GABA-T with IC50 of 0.55 mg/ml, inhibition decreases in the order: methanol extract, water extract, ethyl acetate extract and hexane extract (not inhibitory)
-
additional information
-
no inhibition by 3-aminopropane-1-sulfonic acid, isoguvacine (i.e. 1,2,3,4-tetrahydro-1-methyl-3-pyridine carboxylic acid), baclofen (i.e. beta-(aminomethyl)-4-chlorobenzenepropanoic acid), bicuculline, picrotoxin, Schistocerca gregaria: antiserum against sheep enzyme
-
additional information
-
no inhibition by chelating agents, non-substrate L- or D-amino acids, metal ions
-
additional information
-
(+/-)-(1S,3S,4S)-3-amino-4-fluorocyclohexanecarboxylic acid and (cis)-3-amino-5,5-difluorocylcohexanecarboxylic acid are no an inhibitors of GABA-AT at a concentration of 10 mM
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.1 - 1.6
(4R)-4-amino-1-cyclopentene-1-carboxylic acid
0.059
(R)-4-amino-3-fluorobutanoic acid
pH 8.5
0.045
(R,S)-4-amino-3-fluorobutanoic acid
pH 8.5
8
1H-tetrazole-5-butanamine
-
pH 8.5
2.3
1H-tetrazole-5-ethanamine
-
pH 8.5
2.4
1H-tetrazole-5-propanamine
-
pH 8.5
0.0021 - 46
2-oxoglutarate
8.5
3-Aminopropanesulfonate
Km apparent value
1.4
4-(aminomethyl)-1H-pyrrole-2-carboxylic acid
-
pH 8.5, 25°C
0.31
4-(aminomethyl)furan-2-carboxylic acid
-
pH 8.5, 25°C
2.8
4-(aminomethyl)furan-3-carboxylic acid
-
pH 8.5, 25°C
1.7
4-(aminomethyl)thiophene-2-carboxylic acid
-
pH 8.5, 25°C
10
4-(aminomethyl)thiophene-3-carboxylic acid
-
pH 8.5, 25°C
0.077 - 146
4-aminobutanoate
9.9
4-aminobutyrate
Km apparent value
0.014
4-Oxobutanoate
with L-alanine as cosubstrate, in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
9.5
5-(aminomethyl)-1H-pyrrole-2-carboxylic acid
-
pH 8.5, 25°C
2.49
5-(aminomethyl)furan-2-carboxylic acid
-
pH 8.5, 25°C
6.3
5-(aminomethyl)thiophene-2-carboxylic acid
-
pH 8.5, 25°C
0.1
alpha-ketoglutarate
-
pH 8.4, 25°C
2.3
DL-3-amino-1-cyclopentene-1-carboxylic acid
-
-
3.2
gamma-aminobutanoate
pH 8.0, 30°C
2.6
gamma-aminobutanoic acid
pH 8.5
2.72
L-3-aminoisobutanoate
-
-
2.4
L-alanine
with 4-oxobutanoate as cosubstrate, in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
8
tetrazole-5-butanamine
-
at 25°C in 50 mM potassium diphosphate buffer, pH 8.5, containing 2 mM beta-mercaptoethanol
2.3
tetrazole-5-ethanamine
-
at 25°C in 50 mM potassium diphosphate buffer, pH 8.5, containing 2 mM beta-mercaptoethanol
2.4
tetrazole-5-propanamine
-
at 25°C in 50 mM potassium diphosphate buffer, pH 8.5, containing 2 mM beta-mercaptoethanol
additional information
additional information
-
0.1
(4R)-4-amino-1-cyclopentene-1-carboxylic acid

-
-
1.6
(4R)-4-amino-1-cyclopentene-1-carboxylic acid
-
-
0.0021
2-oxoglutarate

mutant E211S, 25°C, pH 7.8
0.063
2-oxoglutarate
mutant E211S/I50H/V80T, 25°C, pH 7.8
0.11
2-oxoglutarate
-
25°C, pH 8.4
0.13
2-oxoglutarate
mutant V241A, 25°C, pH 7.8
0.13 - 0.27
2-oxoglutarate
-
-
0.13 - 0.27
2-oxoglutarate
-
37°C, pH 8.0
0.13 - 0.27
2-oxoglutarate
-
37°C, pH 7.3
0.22
2-oxoglutarate
-
pH 8.5
0.22
2-oxoglutarate
pH 8.0, 30°C
0.22
2-oxoglutarate
in 100 mM potassium phosphate (pH 8.0), 0.1 mM pyridoxal 5'-phosphate
0.27
2-oxoglutarate
-
pH 8.5
0.47
2-oxoglutarate
-
pH 8.6, 25°C
0.7
2-oxoglutarate
-
37°C
0.72
2-oxoglutarate
mutant E211S/I50G/C77K, 25°C, pH 7.8
0.78
2-oxoglutarate
mutant I50Q/G295Y, 25°C, pH 7.8
1
2-oxoglutarate
-
pH 8.4, 25°C
1.07
2-oxoglutarate
wild-type, 25°C, pH 7.8
1.3 - 1.5
2-oxoglutarate
-
-
1.5
2-oxoglutarate
Candida guilliermondii var. membranaefaciens
-
-
2.1
2-oxoglutarate
pH 8.0, 30°C
2.8
2-oxoglutarate
-
pH 8.0, 37°C
5.5
2-oxoglutarate
-
38°C, pH 8.5
6.3
2-oxoglutarate
Km apparent value
8.3
2-oxoglutarate
-
pH 8.0, 37°C
46
2-oxoglutarate
mutant I50Q, 25°C, pH 7.8
0.077
4-aminobutanoate

pH 9, 25°C, fixed substrate: pyruvate
0.099
4-aminobutanoate
pH 9, 25°C, fixed substrate: glyoxylate
0.135
4-aminobutanoate
pH 9, 25°C, fixed substrate: glyoxylate
0.165
4-aminobutanoate
pH 9, 25°C, fixed substrate: pyruvate
0.18
4-aminobutanoate
with glyoxylate as cosubstrate, in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
0.34
4-aminobutanoate
with pyruvate as cosubstrate, in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
0.79
4-aminobutanoate
-
pH 8.5
0.79
4-aminobutanoate
-
pH 8.6, 25°C
1.1
4-aminobutanoate
-
37°C
1.1
4-aminobutanoate
-
37°C, pH 8.0
1.2
4-aminobutanoate
-
pH 8.2
1.27
4-aminobutanoate
-
25°C, pH 8.4
1.3
4-aminobutanoate
-
pH 8.5, 25°C
1.7
4-aminobutanoate
-
pH 8.0, 37°C
2.2
4-aminobutanoate
-
pH 8.6, temperature not specified in the publication
2.2 - 2.3
4-aminobutanoate
-
-
2.2 - 2.3
4-aminobutanoate
Candida guilliermondii var. membranaefaciens
-
-
2.2 - 2.3
4-aminobutanoate
-
pH 8.5
2.4
4-aminobutanoate
-
pH 8.5
2.4
4-aminobutanoate
-
at 25°C in 50 mM potassium diphosphate buffer, pH 8.5, containing 2 mM beta-mercaptoethanol
3.2
4-aminobutanoate
in 100 mM potassium phosphate (pH 8.0), 0.1 mM pyridoxal 5'-phosphate
3.3
4-aminobutanoate
-
pH 8.0, 37°C
3.3 - 4.8
4-aminobutanoate
-
-
3.3 - 4.8
4-aminobutanoate
-
pH 8.0, 37°C
4
4-aminobutanoate
-
38°C, pH 8.5
4.7
4-aminobutanoate
mutant I50Q/G295Y, 25°C, pH 7.8
5.8
4-aminobutanoate
wild-type, 25°C, pH 7.8
5.9
4-aminobutanoate
mutant E211S/I50G/C77K, 25°C, pH 7.8
6.5
4-aminobutanoate
-
mitochondrial enzyme
6.5
4-aminobutanoate
-
pH 8.0
12.8
4-aminobutanoate
-
at pH 8.4 and 38°C
30
4-aminobutanoate
mutant V241A, 25°C, pH 7.8
53
4-aminobutanoate
-
synaptosomal enzyme, pH 8.0
68
4-aminobutanoate
mutant I50Q, 25°C, pH 7.8
86
4-aminobutanoate
mutant E211S, 25°C, pH 7.8
146
4-aminobutanoate
mutant E211S/I50H/V80T, 25°C, pH 7.8
1.05
beta-Alanine

-
-
4.4
beta-Alanine
-
pH 8.0, 37°C
7.6
beta-Alanine
pH 8.0, 30°C
0.0165
glyoxylate

pH 9, 25°C, fixed substrate: 4-aminobutanoate
0.039
glyoxylate
pH 9, 25°C, fixed substrate: 4-aminobutanoate
0.11
glyoxylate
in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
0.0188
pyruvate

pH 9, 25°C, fixed substrate: 4-aminobutanoate
0.023
pyruvate
pH 9, 25°C, fixed substrate: 4-aminobutanoate
0.14
pyruvate
in 50 mM TABS (pH 9), 1.5 mM dithiothreitol, 0.625 mM EDTA, 0.1 mM pyridoxal 5'-phosphate, 10% (v/v) glycerol, at 30°C
additional information
additional information

-
-
-
additional information
additional information
-
-
-
additional information
additional information
-
-
-
additional information
additional information
-
kinetic study
-
additional information
additional information
-
pH-dependence of kinetic data
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0183
isoform GABA-T2, using pyruvate as amino cceptor
0.0209
isoform GABA-T2, using glyoxylate as amino cceptor
0.1
substrate beta-alanine, discontinuous determination of glutamate using glutamate dehydrogenase in the presence of 10 M hydrazine, pH 8.0, 30°C
0.13
substrate beta-alanine, continuous assay using malonic semialdehyde decarboxylase and alcohol dehydrogenase, pH 8.0, 30°C
0.14
substrate beta-alanine, discontinuous determination of glutamate using glutamate dehydrogenase in the presence of 10 M hydrazine, pH 8.0, 30°C
0.15
substrate beta-alanine, discontinuous determination of glutamate using glutamate dehydrogenase in the presence of 10 M hydrazine, pH 8.0, 30°C
0.1785
isoform GABA-T3, using glyoxylate as amino acceptor
0.2065
isoform GABA-T3, using pyruvate as amino acceptor
0.75
substrate gamma-aminobutanoate, continuous assay with succinate dehydrogenase, pH 8.0, 30°C
1.6
substrate gamma-aminobutanoate, continuous assay using malonic semialdehyde decarboxylase and alcohol dehydrogenase, pH 8.0, 30°C
170
-
pH 7.3, 37°C, liver enzyme
260
-
pH 7.3, 37°C, kidney enzyme
3.495
isoform GABA-T1, using glyoxylate as amino acceptor
3.52
substrate beta-alanine, discontinuous determination of glutamate using glutamate dehydrogenase in the presence of 10 M hydrazine, pH 8.0, 30°C
3.6
substrate gamma-aminobutanoate, continuous assay using malonic semialdehyde decarboxylase and alcohol dehydrogenase, pH 8.0, 30°C
3.67
continuous assay using malonic semialdehyde decarboxylase and alcohol dehydrogenase, pH 8.0, 30°C
4.5
substrate beta-alanine, continuous assay using malonic semialdehyde decarboxylase and alcohol dehydrogenase, pH 8.0, 30°C
5.79
isoform GABA-T1, using pyruvate as amino acceptor
52.33
Candida guilliermondii var. membranaefaciens
-
-
600
-
pH 7.3, 37°C, brain enzyme
12.8

using 4-aminobutanoate as substrate
12.8
substrate gamma-aminobutanoate, continuous assay with succinate dehydrogenase, pH 8.0, 30°C
4.9

-
-
additional information

specific activity is 52% with oxaloacetate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
-
specific activity is 52% with oxaloacetate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
specific activity is 59% with glyoxalate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
-
specific activity is 59% with glyoxalate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
specific activity is 63% with pyruvate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
-
specific activity is 63% with pyruvate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
specific activity is 9% with 2-oxobutyrate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
-
specific activity is 9% with 2-oxobutyrate as amino group acceptor (normalized to that with 2-oxoglutarate (100%: 46 mkat/kg protein)), the donor is homotaurine
additional information
specific activity of 0.02 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with ammonium as the sole nitrogen source, substrate is homotaurine
additional information
-
specific activity of 0.02 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with ammonium as the sole nitrogen source, substrate is homotaurine
additional information
specific activity of 0.03 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with ammonium as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
-
specific activity of 0.03 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with ammonium as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
specific activity of 6.5 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with 4-aminobutyrate as the sole nitrogen source, substrate is homotaurine
additional information
-
specific activity of 6.5 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with 4-aminobutyrate as the sole nitrogen source, substrate is homotaurine
additional information
specific activity of 8.0 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is succinate semialdehyde
additional information
-
specific activity of 8.0 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is succinate semialdehyde
additional information
specific activity of 8.2 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with 4-aminobutyrate as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
-
specific activity of 8.2 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with 4-aminobutyrate as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
specific activity of 8.3 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is homotaurine
additional information
-
specific activity of 8.3 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is homotaurine
additional information
specific activity of 9.9 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
-
specific activity of 9.9 mkat/kg protein is detected in crude cell extracts of Cupriavidus necator grown with homotaurine as the sole nitrogen source, substrate is 4-aminobutyrate
additional information
specific activity with 3-aminopropanoate, taurine, (S)-cysteate, 3-aminopropanol or 4-aminobutanol as substrates is not detected
additional information
-
specific activity with 3-aminopropanoate, taurine, (S)-cysteate, 3-aminopropanol or 4-aminobutanol as substrates is not detected
additional information
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 226% with 5-aminovalerate 6-aminocapronate as substrate
additional information
-
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 226% with 5-aminovalerate 6-aminocapronate as substrate
additional information
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 25% with 6-aminocapronate as substrate
additional information
-
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 25% with 6-aminocapronate as substrate
additional information
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 270% with 4-aminobutyrate as substrate
additional information
-
specific activity, normalized to that with homotaurine (100%: 271 mkat/kg protein), is 270% with 4-aminobutyrate as substrate
additional information
-
stable-isotope dilution assay
additional information
-
3.4 units/mg in crude brain homogenate and 51.2 units/mg after 15fold purification
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.